EP Patent

EP2578191A1 — Apparatus for intraocular injection

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-04-10 · 13y expired

What this patent protects

Described is a medicament delivery device comprising a body (1) adapted to accommodate a cartridge (2) containing a medicament (3), and a reservoir (7, 17) coupled to the body (1), the reservoir (7, 17) containing a fluid (13) and a plunger (8, 18). The cartridge (2) is axially m…

USPTO Abstract

Described is a medicament delivery device comprising a body (1) adapted to accommodate a cartridge (2) containing a medicament (3), and a reservoir (7, 17) coupled to the body (1), the reservoir (7, 17) containing a fluid (13) and a plunger (8, 18). The cartridge (2) is axially movable relative to the body (1) between a retracted position and an extended position. Axial movement of the cartridge (2) from the retracted position to the extended position moves the plunger (8, 18) to expel the fluid (13) from the reservoir (7, 17).

Drugs covered by this patent

Patent Metadata

Patent number
EP2578191A1
Jurisdiction
EP
Classification
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.